Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels

dc.contributor.author
Bonnín Roig, Caterina del Mar
dc.contributor.author
Valls Roig, Èlia
dc.contributor.author
Rosa, Adriane R.
dc.contributor.author
Reinares, María
dc.contributor.author
Jiménez Martínez, Ester
dc.contributor.author
Solé Cabezuelo, Brisa
dc.contributor.author
Montejo Egido, Laura
dc.contributor.author
Meseguer, Ana
dc.contributor.author
Pacchiarotti, Isabella
dc.contributor.author
Colom, Francesc, 1971-
dc.contributor.author
Martínez-Arán, Anabel, 1971-
dc.contributor.author
Tomioka, Yoko
dc.contributor.author
Vieta i Pascual, Eduard, 1963-
dc.contributor.author
Torrent Font, Carla
dc.date.issued
2026-02-12T14:12:52Z
dc.date.issued
2026-02-12T14:12:52Z
dc.date.issued
2019-06
dc.date.issued
2026-02-12T14:12:53Z
dc.identifier
0924-977X
dc.identifier
https://hdl.handle.net/2445/226829
dc.identifier
690013
dc.identifier
31076186
dc.description.abstract
The main aim of this study is to evaluate the impact of functional remediation (FR) in serum brain derived neurotrophic factor (BDNF) levels in euthymic adult patients with Bipolar Disorder (BD). A total of 128 participants were recruited at the Hospital Clinic of Barcelona. They were assessed at baseline and at the end of follow-up by the means of Hamilton Depression Scale (HAM-D), Young Mania Rating Scale (YMRS) and Functioning Assessment Short Test (FAST), as well as a clinical structured interview to collect clinical and demographic variables of interest. Blood samples were also collected to assess BDNF levels. After baseline assessment, patients received FR, Psychoeducation or treatment as usual (TAU). One hundred and two out of 126 participants finished the study distributed as follows: FR group (n = 39); Psychoeducation group (n = 47) and TAU group (n = 16). Longitudinal repeated-measures analyses addressing the treatment effect on BDNF levels showed non-significant differences between the three groups (Pillai's trace = 0.06; F(2,97)= 0.28; p = 0.75), suggesting no interaction between treatment allocation and time on BDNF levels. The results of this study suggest that FR has no effect on peripheral BDNF levels in euthymic patients with BD, despite the improvement in psychosocial functioning.
dc.format
47 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2019.04.002
dc.relation
European Neuropsychopharmacology, 2019, vol. 29, num.6, p. 701-710
dc.relation
https://doi.org/10.1016/j.euroneuro.2019.04.002
dc.rights
cc-by-nc-nd (c) Elsevier B.V., 2019
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Trastorn bipolar
dc.subject
Intervenció psicològica
dc.subject
Manic-depressive illness
dc.subject
Psychological intervention
dc.title
Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.